Skip to main navigation Skip to search Skip to main content

A Prospective Randomized Double Blinded Placcbo Controlled Phase II Trial of Intra-Coronary Infusion of AMR-001, a Bone Marrow Derived Autologous CD34+Selected Cell Product, in Patients with Acute Myocardial Infarction

Project: Research

Project Details

StatusFinished
Effective start/end date04/30/1201/12/17

Funding

  • Amorcyte Incorporated: $64,090.15